Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer
Clinical trial NCT05160727 · UNKNOWN
Trial details
- NCT number
- NCT05160727
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2024-10-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.